Bray Capital Advisors Sells 1,762 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Bray Capital Advisors lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 18.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,665 shares of the healthcare conglomerate’s stock after selling 1,762 shares during the quarter. UnitedHealth Group accounts for about 1.0% of Bray Capital Advisors’ investment portfolio, making the stock its 26th biggest position. Bray Capital Advisors’ holdings in UnitedHealth Group were worth $3,878,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $30,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $37,000. Highline Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth about $55,000. Legacy Investment Solutions LLC acquired a new position in UnitedHealth Group in the third quarter valued at about $57,000. Finally, DecisionPoint Financial LLC increased its holdings in shares of UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after buying an additional 62 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on UNH. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. KeyCorp restated an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Oppenheimer increased their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Barclays lowered their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Down 1.6 %

Shares of UNH stock opened at $503.01 on Friday. The firm has a market capitalization of $462.91 billion, a P/E ratio of 32.45, a PEG ratio of 1.40 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm’s fifty day moving average price is $520.37 and its two-hundred day moving average price is $561.26. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same period last year, the business earned $5.83 earnings per share. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.